MGX
Metagenomi, Inc. Common Stock (MGX) PESTLE Analysis Analysis (2026)
No material changes this month.
Overall Score
Political
No major political catalysts or policy changes are evident from the current data.
The company’s small size and limited leverage reduce near-term policy sensitivity.
Economic
TTM profitability remains deeply negative, with net profit margin at -6.89% and operating margin at -7.42%.
Liquidity is strong with a current ratio of 4.50 and cash per share of 3.20, but negative operating cash flow and free cash flow remain a drag.
Valuation is not supported by earnings or cash flow, as EV/EBITDA and EV/FCF are both negative due to losses.
Social
No fresh news indicates a material change in customer sentiment, brand perception, or workforce dynamics.
High R&D intensity at 6.44% of revenue suggests continued dependence on innovation and technical execution.
Technological
R&D spending remains elevated at 6.44% of revenue, supporting ongoing product development.
No new product launches, platform changes, or technology disruptions were reported this month.
Legal
No new litigation, regulatory action, or compliance developments were reported in the latest news.
The effective tax rate is minimal at 0.22%, but there is no evidence of a material legal change.
Environmental
No new environmental, sustainability, or climate-related developments were reported.
Capex remains light relative to revenue, limiting near-term environmental compliance pressure.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Metagenomi, Inc. Common Stock. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.